Work

MA 02.11 A Phase I Trial of Erlotinib and Onalespib in EGFR-mutant NSCLC: Focus on EGFR Exon 20 Insertions

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.459

Authors: J. Riess, K. Reckamp, J. Longmate, K. Kelly, D.R. Gandara, P. Mack, E. Newman, P. Lara

Institutions: University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis, City Of Hope National Medical Center, City of Hope

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2768078110

FWCI:

Cites:

Cited by:

Related to: 10